Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe.

PloS one·2015

Neurodevelopmental theories of schizophernia : application to late-onset schizophernia.

Indian journal of psychiatry·2011

Unrecognised cognitive impairment in hospice patients: a pilot study.

Palliative medicine·2008

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

Journal of viral hepatitis·2008

Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders.

Psychological medicine·2007

Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.

International journal of geriatric psychiatry·2006

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Treating co-occurring alcohol use disorder and major depressive disorder: A systematic review of combination and multimodal pharmacotherapy.

The American journal on addictions·2026

From Pharmacological Uncertainty to Inhalation Development: An Evidence-Gated Roadmap for Codonopsis-Derived Triterpenoid Saponins.

Drug design, development and therapy·2026

Local field potential biomarkers for adaptive deep brain stimulation in Parkinson's disease: A scoping review.

Surgical neurology international·2026

Safety study of sitagliptin combined with metoprolol on the treatment of elderly patients with type 2 diabetes mellitus and hypertension.

Open medicine (Warsaw, Poland)·2026

Comparative Analysis of Antidepressant Mechanisms and Side Effects: Network Pharmacology and Molecular Docking Study of Amitriptyline, Mirtazapine, and Escitalopram for Treating Major Depressive Disorder.

Depression and anxiety·2026

Thermodynamic Basis of Paton's Rate Theory of Drug Action: Occupation Theory as Its Steady-State Limit.

Cureus·2026

Related Experiment Videos

Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia

Related Concept Videos

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe.

Neurodevelopmental theories of schizophernia : application to late-onset schizophernia.

Unrecognised cognitive impairment in hospice patients: a pilot study.

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders.

Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Treating co-occurring alcohol use disorder and major depressive disorder: A systematic review of combination and multimodal pharmacotherapy.

From Pharmacological Uncertainty to Inhalation Development: An Evidence-Gated Roadmap for Codonopsis-Derived Triterpenoid Saponins.

Local field potential biomarkers for adaptive deep brain stimulation in Parkinson's disease: A scoping review.

Safety study of sitagliptin combined with metoprolol on the treatment of elderly patients with type 2 diabetes mellitus and hypertension.

Comparative Analysis of Antidepressant Mechanisms and Side Effects: Network Pharmacology and Molecular Docking Study of Amitriptyline, Mirtazapine, and Escitalopram for Treating Major Depressive Disorder.

Thermodynamic Basis of Paton's Rate Theory of Drug Action: Occupation Theory as Its Steady-State Limit.

Related Experiment Videos

Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia

Related Concept Videos

Related Articles